Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works

10-year follow-up of intensive glucose control in type 2 diabetes

Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · see citing works

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes

(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138 · see citing works

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · see citing works

Effect of a multifactorial intervention on mortality in type 2 diabetes

Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,489 · see citing works

Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy

(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534 · see citing works

Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood

Bhargava, S. K., Sachdev, H. S., Fall, C. H. D., Osmond, C., Lakshmy, R., Barker, D. J. P., Biswas, S. K. D., Ramji, S., Prabhakaran, D., & Reddy, K. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035698 · Cited by 1,037 · see citing works

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

Gæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981 · see citing works

Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease

Ference, B. A., Yoo, W., Alesh, I., Mahajan, N., Mirowska, K. K., Mewada, A., Kahn, J., Afonso, L., Williams, K. A., & Flack, J. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.017 · Cited by 898 · see citing works

EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY

Parving, H., Smidt, U., Andersen, A. R., & Svendsen, P. A. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92462-5 · Cited by 864 · see citing works

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., Arima, H., Monaghan, H., Joshi, R., Colagiuri, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407963 · Cited by 626 · see citing works

Clinical Inertia in People With Type 2 Diabetes

Khunti, K. K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2013) · Diabetes Care · doi:10.2337/dc13-0331 · Cited by 615 · see citing works

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the STENO-2 randomised trial

Gæde, P., Oellgaard, J., Carstensen, B., Rossing, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2016) · Diabetologia · doi:10.1007/s00125-016-4065-6 · Cited by 528 · see citing works

Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals

Okonofua, E. C., Simpson, K. N., Jesri, A., Rehman, S. U., Durkalski, V. L., & Egan, B. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000200702.76436.4b · Cited by 527 · see citing works

Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women

Wilmot, K. A., O’Flaherty, M., Capewell, S., Ford, E. S., & Vaccarino, V. (2015) · Circulation · doi:10.1161/circulationaha.115.015293 · Cited by 522 · see citing works

Epigenetic mechanisms in diabetic complications and metabolic memory

Reddy, M. A., Zhang, E., & Natarajan, R. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3462-y · Cited by 498 · see citing works

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality

Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437 · see citing works

The “Metabolic Memory”: Is More Than Just Tight Glucose Control Necessary to Prevent Diabetic Complications?

Ceriello, A., Ihnat, M. A., & Thorpe, J. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1824 · Cited by 411 · see citing works

Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study

Ford, I., Murray, H., McCowan, C., & Packard, C. J. (2016) · Circulation · doi:10.1161/circulationaha.115.019014 · Cited by 238 · see citing works

8. Cardiovascular Disease and Risk Management

American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s011 · Cited by 236 · see citing works

The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK

Sever, P., Chang, C. L., Gupta, A. K., Whitehouse, A., & Poulter, N. R. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr333 · Cited by 124 · see citing works

Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits

Oellgaard, J., Gæde, P., Rossing, P. R., Persson, F., Parving, H., & Pedersen, O. B. (2017) · Kidney International · doi:10.1016/j.kint.2016.11.023 · Cited by 118 · see citing works

Metabolic memory: Mechanisms and implications for diabetic retinopathy

Zhang, L., Chen, B., & Tang, L. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.006 · Cited by 96 · see citing works

Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)

for the VADT Study Group, Agrawal, L., Azad, N., Bahn, G. D., Ge, L., Reaven, P. D., Hayward, R. A., Reda, D. J., & Emanuele, N. V. (2018) · Diabetologia · doi:10.1007/s00125-017-4473-2 · Cited by 92 · see citing works

Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS)

Chiang, C., Ferrières, J., Gotcheva, N. N., Raal, F. J., Shehab, A., Sung, J., Henriksson, K. M., & Hermans, M. P. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.31179 · Cited by 63 · see citing works

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

Paul, S. K., Klein, K., Maggs, D. G., & Best, J. H. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0178-3 · Cited by 55 · see citing works

Persistence of Mortality Reduction After the End of Randomized Therapy in Clinical Trials of Blood Pressure–Lowering Medications

Kostis, W. J., Thijs, L., Richart, T., Kostis, J. B., & Staessen, J. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.160291 · Cited by 43 · see citing works

Antihypertensive Therapy in Diabetes: The Legacy Effect and RAAS Blockade

Volpe, M., Cosentino, F., Tocci, G., Palano, F., & Paneni, F. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0205-z · Cited by 31 · see citing works

Continuation of mortality reduction after the end of randomized therapy in clinical trials of lipid-lowering therapy

Kostis, W. J., Moreyra, A. E., Cheng, J., Dobrzynski, J. M., & Kostis, J. B. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.01.006 · Cited by 23 · see citing works

Metabolic memory and all‐cause death in community‐based patients with type 2 diabetes: the Fremantle Diabetes Study

Davis, T. M. E., Chubb, S. A. P., Bruce, D. G., & Davis, W. A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12655 · Cited by 21 · see citing works

Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD)

Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · see citing works

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455 · see citing works

10. Cardiovascular Disease and Risk Management: <i>Standards of Care in Diabetes—2024</i>

American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Das, S. R., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s010 · Cited by 438 · see citing works

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025

American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Das, S. R., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s010 · Cited by 339 · see citing works

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

Carr, M., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K. (2021) · BMJ Quality & Safety · doi:10.1136/bmjqs-2021-013613 · Cited by 223 · see citing works

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026

American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s010 · Cited by 107 · see citing works

Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK

Carr, M., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00116-9 · Cited by 114 · see citing works

Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years

Lawson, C. A., Seidu, S., Zaccardi, F., McCann, G. P., Kadam, U. T., Davies, M. J., Lam, C. S. P., Heerspink, H. J. L., & Khunti, K. K. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100739 · Cited by 98 · see citing works

Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990–2017: A cohort study

Mathur, R., Farmer, R. E., Eastwood, S. V., Chaturvedi, N., Douglas, I., & Smeeth, L. L. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003106 · Cited by 79 · see citing works

Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta‐analysis of trials investigating intensive glucose‐lowering strategies in people with type 2 diabetes

Kunutsor, S. K., Balasubramanian, V. G., Zaccardi, F., Gillies, C. L., Aroda, V. R., Seidu, S., & Khunti, K. K. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15511 · Cited by 78 · see citing works

A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus

Su, L., Xin, C., Yang, J., Dong, L., Mei, H., Dai, X., & Wang, Q. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.06.071 · Cited by 67 · see citing works

2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care

Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. K. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.002 · Cited by 54 · see citing works

Long COVID — metabolic risk factors and novel therapeutic management

Khunti, K. K., Davies, M. J., Kosiborod, M., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00495-0 · Cited by 47 · see citing works

A Noninvasive, Economical, and Instant-Result Method to Diagnose and Monitor Type 2 Diabetes Using Pulse Wave: Case-Control Study

Hao, Y., Cheng, F., Pham, M., Rein, H. L., Patel, D., Fang, Y., Feng, Y., Yan, J., Song, X., Yan, H., et al. (2019) · JMIR mhealth and uhealth · doi:10.2196/11959 · Cited by 47 · see citing works

Influential Factors in Adherence to the Therapeutic Regime in Hypertension and Diabetes

Parra, D. I., Guevara, S. L. R., & Rojas, L. Z. (2019) · Investigación y Educación en Enfermería · doi:10.17533/udea.iee.v37n3e02 · Cited by 46 · see citing works

Cardiovascular Benefit of Empagliflozin Across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME Trial

Inzucchi, S. E., Khunti, K. K., FITCHETT, D. H., Wanner, C., Mattheus, M., George, J. T., Ofstad, A. P., & Zinman, B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa321 · Cited by 46 · see citing works

A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe

Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. K. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.05.004 · Cited by 45 · see citing works

Therapeutic Inertia and the Legacy of Dysglycemia on the Microvascular and Macrovascular Complications of Diabetes

Khunti, K., & Seidu, S. (2019) · Diabetes Care · doi:10.2337/dci18-0030 · Cited by 44 · see citing works

Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents

Kunutsor, S. K., Zaccardi, F., Balasubramanian, V. G., Gillies, C. L., Aroda, V. R., Seidu, S., Davies, M. J., & Khunti, K. K. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15500 · Cited by 42 · see citing works

The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study

Cai, X., Hu, D., Pan, C., Li, G., Lu, J., Ji, Q., Su, B., Tian, H., Qu, S., Weng, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44169-4 · Cited by 41 · see citing works

The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care

Russo, G., Di Bartolo, P., Candido, R., Lucisano, G., Manicardi, V., Giandalia, A., Nicolucci, A., Rocca, A., Rossi, M. C., & Di Cianni, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110672 · Cited by 39 · see citing works

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

Bosch, J., Lonn, E., Jung, H., Zhu, J., Liu, L., López-Jaramillo, P. A., Pais, P. S., Xavier, D., Díaz, R., Dagenais, G. R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab225 · Cited by 39 · see citing works

Re‐examining the widespread policy of stopping sodium‐glucose cotransporter‐2 inhibitors during acute illness: A perspective based on the updated evidence

Khunti, K., Aroda, V. R., Bhatt, D. L., Bozkurt, B., Buse, J. B., Heerspink, H. L., Inzucchi, S. E., Lam, C. S. P., Marx, N., McMurray, J. J. V., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14805 · Cited by 37 · see citing works

Oil tea improves glucose and lipid levels and alters gut microbiota in type 2 diabetic mice

Lin, R., He, X. M., Chen, H., He, Q., Yao, Z., Li, Y., Yang, H., & Simpson, S. (2018) · Nutrition Research · doi:10.1016/j.nutres.2018.05.004 · Cited by 38 · see citing works

Weight change and risk of obesity‐related complications: A retrospective population‐based cohort study of a UK primary care database

Khunti, K. K., Schnecke, V., Haase, C. L., Harder-Lauridsen, N. M., Rathor, N., Matthiessen, K. S., & Morgen, C. S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15154 · Cited by 35 · see citing works

Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes

Patel, P., Gupta, P., Burns, A., Suwaidan, A. A., Cole, R., Lane, D., Seidu, S., & Khunti, K. K. (2019) · Diabetes Care · doi:10.2337/dc18-1453 · Cited by 31 · see citing works

Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: A real‐world study of patients followed for up to 19 years

Coles, B., Zaccardi, F., Hvid, C. A., Davies, M. J., & Khunti, K. K. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14218 · Cited by 29 · see citing works

Effects of Camellia tea and herbal tea on cardiometabolic risk in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials

Wang, P., Ma, X. M., Geng, K., Jiang, Z. Z., Yan, P. Y., & Xu, Y. (2022) · Phytotherapy Research · doi:10.1002/ptr.7572 · Cited by 30 · see citing works

Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 Diabetes

Khunti, K. K., & Aroda, V. R. (2022) · Diabetes Care · doi:10.2337/dci21-0064 · Cited by 24 · see citing works

Low glycemic index potato biscuits alleviate physio-histological damage and gut dysbiosis in rats with type-2 diabetes mellitus induced by high-sugar and high-fat diet and streptozotocin

Zhao, R., Li, N., Liu, W., Liu, Q., Zhang, L., Peng, X., Zhao, R., & Hu, H. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109401 · Cited by 20 · see citing works

The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes

Kim, G. S., Park, J. H., & Won, J. C. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.2.106 · Cited by 20 · see citing works

The rapidly increasing incidence of type 2 diabetes and macrovascular and microvascular complications disproportionately affects younger age groups: A decade of evidence from an international federated database

Anson, M., Henney, A. E., Edwards, H., Ibarburu, G. H., Mordi, I. R., Jaffar, S. S., Garrib, A. V., Lip, G. Y. H., Wang, D., Nabrdalik, K., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112431 · Cited by 21 · see citing works

Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management

Vora, J. P., Cherney, D. Z. I., Kosiborod, M., Spaak, J., Kanumilli, N., Khunti, K. K., Lam, C. S. P., Bachmann, M., Fenici, P., & the CaReMe Global Alliance (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15485 · Cited by 19 · see citing works

Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed

Mata‐Cases, M., Franch‐Nadal, J., Gratacòs, M., & Mauricio, D. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0018 · Cited by 18 · see citing works

Overcoming Therapeutic Inertia as the Achilles’ Heel for Improving Suboptimal Diabetes Care: An Integrative Review

Chew, B., Yusof, B. N. M., Lai, P. S. M., & Khunti, K. K. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1649 · Cited by 18 · see citing works

Plant‐based diets could ameliorate the risk factors of cardiovascular diseases in adults with chronic diseases

Lotfi, M., Nouri, M., Jalil, A. T., Rezaianzadeh, A., Babajafari, S., Johari‬, M. G., & Faghih, S. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.3164 · Cited by 17 · see citing works

The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes

Nørgaard, C. H., Mosslemi, M., Lee, C. J., Torp-Pedersen, C. T., & Wong, N. D. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1123-y · Cited by 18 · see citing works

The Legacy Effect in the Prevention of Cardiovascular Disease

Esmel, E. V., Naval-Álvarez, J., & Sacanella, E. (2020) · Nutrients · doi:10.3390/nu12113227 · Cited by 17 · see citing works

Insulin Resistance in Long COVID-19 Syndrome

Man, D. E., Andor, M., Buda, V. O., Kundnani, N. R., Duda-Seiman, D. M., Craciun, L. M., Nicula, M., Carlogea, I.-S., & Dragan, S. R. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14090911 · Cited by 16 · see citing works

Mechanisms and pathophysiology of SARS-CoV-2 infection of the adipose tissue

Moser, J., Emous, M., Heeringa, P., & Rodenhuis‐Zybert, I. A. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.08.010 · Cited by 16 · see citing works

Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021

An, J., Jia, Y., Shi, X., He, X., Zhang, J., Ren, Y., & He, Q. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16199 · Cited by 15 · see citing works

Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study

Patel, K., Gomes, M. B., Charbonnel, B. H., Chen, H., Cid‐Ruzafa, J., Fenici, P., Hammar, N., Ji, L., Kennedy, K. F., Khunti, K., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14180 · Cited by 14 · see citing works

Evidence-Based Cardiovascular Risk Management in Diabetes

Mooradian, A. D. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00336-6 · Cited by 15 · see citing works

Sequelae of long COVID, known and unknown: A review of updated information

Asakawa, T., Cai, Q., Shen, J., Zhang, Y., Li, Y., Chen, P., Luo, W., Zhang, J., Zhou, J., Zeng, H., et al. (2023) · BioScience Trends · doi:10.5582/bst.2023.01039 · Cited by 12 · see citing works

Adherence of physicians to evidence-based management guidelines for treating type 2 diabetes and atherosclerotic cardiovascular disease in Ajman, United Arab Emirates

Alliabi, F., Jaber, A. A. S., Jallo, M. K. I., & Baig, M. R. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01672-4 · Cited by 11 · see citing works

Cardiovascular Risk Factor Burden in People With Incident Type 2 Diabetes in the U.S. Receiving Antidiabetic and Cardioprotective Therapies

Montvida, O., Cai, X., & Paul, S. K. (2019) · Diabetes Care · doi:10.2337/dc18-1865 · Cited by 10 · see citing works

Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary carePreprint

Carr, M., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K. (2020) · medRxiv · doi:10.1101/2020.10.25.20200675 · Cited by 11 · see citing works

Legacy in Cardiovascular Risk Factors Control: From Theory to Future Therapeutic Strategies?

Pothen, L., & Balligand, J. (2021) · Antioxidants · doi:10.3390/antiox10111849 · Cited by 11 · see citing works

Association and relative importance of multiple risk factor control on cardiovascular disease, end-stage renal disease and mortality in people with type 2 diabetes: A population-based retrospective cohort study

Usman, M., Khunti, K., Davies, M. J., & Gillies, C. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.08.008 · Cited by 10 · see citing works

Changes in the Prescription of Glucose‐Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study

Fadini, G. P., Frison, V., Simioni, N., Lapolla, A., Gatti, A., Bossi, A. C., Buono, A. D., Fornengo, P., Gottardo, L., Laudato, M., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012244 · Cited by 10 · see citing works

Manejo de la hiperglucemia con fármacos no insulínicos en pacientes adultos con diabetes tipo 2

Guisasola, F. Á., Orozco‐Beltrán, D., Cuenca, A. M. C., Quintero, M. A. R., Angullo-Martínez, E., Lachica, L. Á., Millán, C. O., Caride-Miana, E., Navarro-Pérez, J., Pérez, J. S., et al. (2019) · Atención Primaria · doi:10.1016/j.aprim.2019.05.014 · Cited by 9 · see citing works

Changes in body mass index, glycosylated hemoglobin A1C , blood pressure, and LDL ‐cholesterol among type 2 diabetes patients in Malaysia : A population‐based longitudinal study

Wan, K. S., Moy, F. M., Mustapha, F. I., Ismail, M., & Hairi, N. N. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13206 · Cited by 9 · see citing works

Improving Therapeutic Adherence and Reducing Therapeutic Inertia in the Management of People with Cardiometabolic Diseases: A Call-to-Action from the Middle East

Almahmeed, W. A., Al-Abadla, Z., Alawadi, F., Alrohmaihi, D., Alshamiri, M. Q., Elbadawi, H., El‐Tamimi, H., Elzouki, A.-N. Y., Farghaly, M., Hafidh, K., et al. (2025) · Advances in Therapy · doi:10.1007/s12325-024-03103-5 · Cited by 9 · see citing works

Developmental Impacts of Epigenetics and Metabolism in COVID-19

Naik, N. C., Patel, M., & Sen, R. (2024) · Journal of Developmental Biology · doi:10.3390/jdb12010009 · Cited by 7 · see citing works

Treatment intensification and therapeutic inertia of antihypertensive therapy among patients with type 2 diabetes and hypertension with uncontrolled blood pressure

Wan, K. S., Moy, F. M., Yusoff, M. F. M., Mustapha, F. I., Ismail, M., Rifin, H. M., Ratnam, K. K. Y., Ismail, H., Chong, K. K., Ahmad, N. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-63617-4 · Cited by 7 · see citing works

N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus

Sun, M., Lu, Z., Chen, W., Lv, S., Fu, N., Yang, Y., Wang, Y., Miao, M., Wu, S., & Zhang, J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119117 · Cited by 7 · see citing works

Diabetes-related complications, glycemic levels, and healthcare utilization outcomes after therapeutic inertia in type 2 diabetes mellitus

McDaniel, C. C., Lo‐Ciganic, W., & Chou, C. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2023.12.004 · Cited by 8 · see citing works

Strategies to alter the trajectory of atherosclerotic cardiovascular disease

Packard, C. J. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000643 · Cited by 7 · see citing works

Mulberry – Nutritional Value, Health Benefits, and its Applications in Food, Biomaterials, and Medicine: A Systematic Review with Bibliometric Analysis

Hu, Z., Su, Y., Jia, J., Bian, X., Gu, Y., Lv, G., Chen, S., & Jiang, N. (2025) · Natural Product Communications · doi:10.1177/1934578x251314698 · Cited by 6 · see citing works

Temporal trends in cardiovascular outcomes and costs among patients with type 2 diabetes

Williams, B. A., RAJPURA, J. R., Paprocki, Y., Kumar, N., Voyce, S. J., Brady, J. P., & Chang, A. R. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.07.012 · Cited by 6 · see citing works

Baseline treatments and metabolic control of 288,913 type 2 diabetes patients in a 10-year retrospective cohort in Malaysia

Wan, K. S., Mustapha, F. I., Chandran, A., Ganapathy, S. S., Zakariah, N., Ramasamy, S., Subbarao, G. R., & Yusoff, M. F. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-44564-y · Cited by 5 · see citing works

Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally.

Rutter, M., Carr, M. J., Wright, A., Kanumilli, N., Milne, N., Jones, E., Elton, P., Ceriello, A., Misra, A., Prato, S. D., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111693 · Cited by 5 · see citing works

The interplay of aging, adipose tissue, and COVID-19: a potent alliance with implications for health

Quarleri, J. F., & Delpino, M. V. (2024) · GeroScience · doi:10.1007/s11357-023-01058-z · Cited by 5 · see citing works

Early postpartum HbA1c after hyperglycemia first detected in pregnancy—Imperfect but not without value

Coetzee, A., Hall, D. R., van de Vyver, M., & Conradie, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282446 · Cited by 5 · see citing works

Hundert Jahre – Insulin bleibt aktuell und notwendig

Landgraf, R., & Aberle, J. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1386-0011 · Cited by 4 · see citing works

Cost-effectiveness of intensive interventions compared to standard care in individuals with type 2 diabetes: A systematic review and critical appraisal of decision-analytic models

Usman, M., Khunti, K. K., Davies, M. J., & Gillies, C. L. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108073 · Cited by 4 · see citing works

Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study

Chudasama, Y., Khunti, K. K., Coles, B., Gillies, C. L., Islam, N., Rowlands, A. V., Seidu, S., Razieh, C., Davies, M. J., Samani, N. J., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.04.003 · Cited by 3 · see citing works

Therapeutic inertia in type 2 diabetes mellitus: a fine line between advancing and de-intensifying

Khunti, K. K., & CHENG, A. Y. Y. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00857-w · Cited by 3 · see citing works

The Role of Statins in Prevention of Cardiovascular Diseases in Real Clinical Practice

IuA, K., & Moscow, R. F. (2021) · Doctor Ru · doi:10.31550/1727-2378-2021-20-11-17-27 · Cited by 3 · see citing works

Management of Hyperglycemia in Type 2 Diabetes: A Summary of New Consensus Report from the American Diabetes Association and the European Association for the Study of Diabetes in 2018

Kim, J. M., & Kim, S. S. (2019) · Journal of Korean Diabetes · doi:10.4093/jkd.2019.20.1.6 · Cited by 3 · see citing works

Individualised targets for insulin initiation in type 2 diabetes mellitus—the influence of physician and practice: a cross-sectional study in eight European countries

Boels, A. M., Koning, E. J. P. D., Vos, R. C., Khunti, K. K., & Rutten, G. E. H. M. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-032040 · Cited by 3 · see citing works

3D facial imaging: a novel approach for metabolic abnormalities risk profiling

Peng, Q., Cheung, Y. K., Liu, Y., Wang, Y., Tan, J., Yang, Y., Wang, J., Han, J. J., Li, J., Liu, F., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2726-8 · Cited by 2 · see citing works

Accreditation Programs in Lifestyle Medicine: New Survey Data and a Proposed European Model

Arkadianos, I., Mechanick, J. I., Hâncu, A., Hanes, I., & van Mieghem, C. A. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-82888-1_22 · Cited by 2 · see citing works

Optimizing lipid-lowering therapy for acute coronary syndrome using a decision support system: insights from a cluster randomized trial

Stevens, C. A. T., Smith, J. L., Brandts, J., Barkas, F., Morales, M. M., Janani, L., Kiru, G., Kaza, N., Cornelius, V. R., Poulter, N. R., et al. (2025) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztaf135 · Cited by 2 · see citing works

Treatment Initiation and Modification Among Patients Diagnosed With Dyslipidemia: Prevalence and Associated Factors

Wuttikul, C., Kaew-umpa, P., Kosumphant, A., Jitranon, P., Kunuphathum, R., & Kaewbut, P. (2026) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2026.15.2.286 · Cited by 2 · see citing works

The effect of ginger on blood sugar and urine protein in patients with type 2 diabetes mellitus; a clinical trial

Foroutan, M., Yarmohamadi, M., Ghorbani, R., & Movahhed, H. (2020) · Journal of Renal Injury Prevention · doi:10.34172/jrip.2022.26813 · Cited by 2 · see citing works

Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care – The countrywide cross‐sectional AUSTRO ‐ PROFIT study

Sourij, H., Azhar, K., Aziz, F., Kojzar, H., Sourij, C., Fasching, P., Clodi, M., Ludvik, B. H., Mader, J. K., Resl, M., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15988 · Cited by 2 · see citing works

The association between dietary patterns and cardiovascular disease risk factors in Iranian adults: a cross-sectional study

Lotfi, M., Jalali, S. M., Leilami, K., Askarpour, M., Shateri, Z., Rezaianzadeh, A., Johari‬, M. G., Nouri, M., & Faghih, S. (2024) · BMC Research Notes · doi:10.1186/s13104-024-06976-5 · Cited by 2 · see citing works

Lipid and lipoprotein particle profiles in patients with type 2 diabetes mellitus: A comparative study between highlanders and lowlanders

Zhang, C., Du, R. H., Wang, S., Yan, Y., Sun, X., Wu, Y., & Li, M. (2025) · Lipids · doi:10.1002/lipd.12441 · Cited by 2 · see citing works

The Role of the Multidisciplinary Team across Primary and Secondary Care

Seidu, S., & Khunti, K. K. (2024) · doi:10.1002/9781119697473.ch74 · Cited by 2 · see citing works

Lipid metabolism disorders in patients with type 2 diabetes mellitus: focus on hypertriglyceridemia

Demidova, T. Y., & Омариевна, У. Ф. (2024) · FOCUS Endocrinology · doi:10.62751/2713-0177-2024-5-2-14 · Cited by 1 · see citing works

Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinion

Lim, S. K., Nishimura, R., Kesavadev, J., Kong, A. P. S., McGill, M. J., Ou, H., Chun Kwan, O., Lee, C., Zhang, X., Ji, L., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113054 · Cited by 1 · see citing works

Real-World Evidence of Tirzepatide in Indian Adults With Type 2 Diabetes: Significant Early Glycemic and Cardiometabolic Benefits

Chandra, K. P., GUPTA, M., Awasthi, R., Pande, A. R., Gupta, N., Kumar, D., Agarwal, V., Gupta, T., AWASTHI, S., & Lachhwani, H. (2026) · Cureus · doi:10.7759/cureus.102866 · Cited by 1 · see citing works

Standard Modifiable Cardiovascular Risk Factors and Prognostic Outcomes in Non-Valvular Atrial Fibrillation Patients on Oral Anticoagulants

Liu, L., Liu, H., Sun, P., Aa, G., Liu, Y., Zhang, Z., Yang, Q., & Zhou, X. (2026) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296261442055 · Cited by 1 · see citing works

The role of bempedoic acid in the management of dyslipidaemia in people with diabetes: an expert opinion of Italian diabetologists

Federici, M., Buzzetti, R., Candido, R., Cosmo, S. D., Pirillo, A., Russo, G., Sesti, G., & Avogaro, A. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03185-1 · Cited by 1 · see citing works

Kardiovaskuläre Erkrankungen und Herzinsuffizienz bei Diabetes: Diagnostik und Management (Update 2026)

Heinzl, M. W., Resl, M., Maier, J., Steinwender, C., Falkensammer, J., Fellinger, P., Steinmaurer, T., Saely, C. H., Hoppichler, F., Stingl, H., et al. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-025-02667-8 · Cited by 1 · see citing works

Whole-grain consumption and cardiometabolic risk: a meta-analysis of randomized trials

Naghshi, S., Kiani, S., Ostadrahimi, A., Jayedi, A., Mobasseri, M., Arefhosseini, S., Tutunchi, H., & Aune, D. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag519 · Cited by 1 · see citing works

Metabolic Disorders and Management of High-Risk Patients

Edmonds, M. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-6223-0.00010-8 · Cited by 1 · see citing works

Effets des traitements anti-hyperglycémiants sur les complications cardiovasculaires et rénales du patient diabétique de type 2 : leçons des grands essais d'intervention

Scheen, A. J. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00010-5

Health behaviors and health services accessibility factors associated with diabetes: a propensity score matching analysis

Çınaroğlu, S. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1853526

Currents Trends and Future Perspectives in Our Epigenetic Signatures

Dobrică, E.-C., Găman, M., Cozma, M.-A., & Creţoiu, S. M. (2022) · doi:10.1002/9781119807704.ch15

“Here it was waiting for me:” Diabetes Diagnosis Pathways and Implications for Health Policy

Chard, S. E., Girling, L., Harris‐Wallace, B., Henderson, L., Roth, E. G., & Eckert, J. K. (2022) · Journal of Elder Policy · doi:10.18278/jep.2.2.4

Efecto Legado como Estrategia de Manejo en las Enfermedades Cardiovasculares, Revisión de Tema a Propósito de un Fenómeno Clínico Complejo

León, J. S. T., Ardila, L. J. P., Santamaria, M. J. C., Quintero, V. Q., Campo, E. R. Z., Corzo, M. J. O., Cantillo, F. A. A., Romero, L. D. J., Medina, R. A. A., Solano, M. J. C., et al. (2024) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v8i1.10179

Managing diabetes and cardiovascular disease

Morris, D. (2025) · Independent Nurse · doi:10.12968/indn.2025.4.18

Nutritional Approach in Diabetes: “OLD BUT GOLD”

Folini, L. (2025) · Springer eBooks · doi:10.1007/978-3-032-01700-0_18

Cardiovascular Disease and Risk Management

(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch17

Assessment of Cardiovascular Risk Factors and Their Clinical Implications in Patients with Type 2 Diabetes Mellitus

Kader, M. A., Hasan, M. R., Ansary, E. A. F., & Rahman, A. (2025) · TAJ Journal of Teachers Association · doi:10.70818/taj.v38i4.0691

Cardiovascular risk factors in adults with type 2 diabetes mellitus: Retrospective study

Ríos, E. D. S. G., Yupari-Azabache, I. L., Otiniano, N. M., & Gómez-Goicochea, N. I. (2026) · F1000Research · doi:10.12688/f1000research.181792.1

The Impact of the Multidisciplinary Team on Medication Adherence in Type 2 Diabetes: A Narrative Review

Kacha, G., HIGHTON, P. J., Funnell, M. P., Seidu, S., & Khunti, K. K. (2026) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s571581

Legacy effect in diabetes mellitus: fact or fiction?

Gómez‐Huelgas, R., Perez-Belmonte, L. M., & Umpierrez, G. E. (2021) · Spanish Journal of Medicine · doi:10.24875/sjmed.m21000003

Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials

Zhang, X., Liu, Y., Zhang, F., Li, J., & Tong, N. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.03.015 · Cited by 18 · see citing works

Therapeutic Inertia and the Legacy of Dysglycemia on the Microvascular and Macrovascular Complications of Diabetes

Khunti, K., & Seidu, S. (2019) · Diabetes Care · doi:10.2337/dci18-0030 · Cited by 44 · see citing works

Forty-four Years of the UK Prospective Diabetes Study: Legacy Effect and Beyond

Bhattacharya, S., Kalra, S., Nagendra, L., & Dutta, D. (2025) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2025.21.1.8 · Cited by 7 · see citing works

Legacy Effects from DCCT and UKPDS: What They Mean and Implications for Future Diabetes Trials

Murray, P. T., Chune, G., & Raghavan, V. A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0128-1 · Cited by 78 · see citing works